rxstat › Shortages › Metformin Saxagliptin

Metformin Saxagliptin shortage status

Discontinued

Source: Health Canada shortage reports · Updated Jul 9, 2026

Metformin Saxagliptin products have been discontinued in Canada. See the reports below for which products and when.
Products affected
0 / 3
Reports on file
3

Reports by product

Discontinued
KOMBOGLYZE
850MG 2.5MG · TABLET · ASTRAZENECA CANADA INC
DIN 02389177
To be discontinued
KOMBOGLYZE
500MG 2.5MG · TABLET · ASTRAZENECA CANADA INC
DIN 02389169
Discontinued
KOMBOGLYZE
2.5MG 1000MG · TABLET · ASTRAZENECA CANADA INC
DIN 02389185

What's happening

One or more Metformin Saxagliptin products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.

Metformin Saxagliptin is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BD).

Recent changes

Common questions

When will Metformin Saxagliptin be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Metformin Saxagliptin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (blood glucose lowering drugs, excl. insulins)

Widespread shortageCanagliflozin2 of 4 reported products affected · est. return Dec 4, 2026Widespread shortageSitagliptin12 of 24 reported products affected · est. return Jan 7, 2027Widespread shortageTirzepatide6 of 6 reported products affectedPartial shortageDapagliflozin4 of 11 reported products affected · est. return Jul 24, 2026Partial shortageDapagliflozin Metformin2 of 6 reported products affected · est. return Jul 24, 2026Partial shortageGliclazide2 of 20 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.